Can a bioactive interbody device reduce the cost burden of achieving lateral lumbar fusion?
Abstract
Intervertebral devices are increasingly utilized for fusion in the lumbar spine, along with a variety of bone graft materials. These various grafting materials often have substantial cost burdens for the surgical procedure, although they are necessary to overcome the limitations in healing capacity for many traditional interbody devices. The use of bioactive interbody fusion devices, which have demonstrable stimulatory capacity for the surrounding osteoblasts and osteoprogenitor cells and allow for osseointegration, may reduce this heavy reliance on osteobiologics for achieving interbody fusion. The objective of this study was to evaluate the rate of successful interbody fusion with a bioactive lateral lumbar interbody titanium implant with limited volume and low-cost graft material.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 01, 2022
- Source ID
- 10.3171/2022.4.spine211070
Entities
People
- Bahar Shahidi
- Behrooz A. Akbarnia
- Fernando Rios
- Gregory M. Mundis
- Hani Malone
- Martin Collier
- Michael Jelousi
- Reilly L. Kidwell
- Robert K. Eastlack
- Shae Galli
Organizations
- Naval Medical Center San Diego
- Scripps Clinic
- University of California, San Diego